ALLENA PHARMACEUTICALS INC (ALNA)
US0181191075 - Common Stock
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 13.46M | 340.00K | 420.00K | 230.00K | |||
| Cash Equivalents | 6.59M | 16.52M | 34.70M | 29.59M | 61.42M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 9.90M | 3.02M | 2.21M | 3.03M | 2.83M | |||
| Total Current Assets | 16.49M | 33.01M | 37.25M | 33.04M | 64.47M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.20M | 1.63M | 1.56M | 950.00K | 510.00K | |||
| Other Non-Current Assets | 123.00K | 123.00K | 120.00K | 120.00K | 250.00K | |||
| Total Non-Current Assets | 1.32M | 1.75M | 1.68M | 1.07M | 760.00K | |||
| TOTAL ASSETS | 17.81M | 34.76M | 38.93M | 34.11M | 65.23M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.90M | 9.85M | 0.00 | 3.99M | 0.00 | |||
| Accrued Expenses | 3.25M | 4.80M | 3.71M | 3.87M | 3.63M | |||
| Accounts Payable | 2.27M | 1.03M | 2.41M | 3.05M | 2.14M | |||
| Total Current Liabilities | 10.43M | 15.68M | 6.12M | 10.91M | 5.76M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 9.85M | 5.99M | 9.98M | |||
| Other Non-Current Liabilities | 3.65M | 210.00K | 390.00K | 10.00K | 30.00K | |||
| Total Non-Current Liabilities | 3.65M | 210.00K | 10.24M | 6.00M | 10.01M | |||
| TOTAL LIABILITIES | 14.07M | 15.89M | 16.36M | 16.91M | 15.77M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -266.70M | -246.45M | -197.79M | -164.94M | -117.61M | |||
| Additional Paid In Capital | 270.33M | 265.24M | 220.31M | 182.12M | 167.04M | |||
| Common Shares | 108.00K | 83.00K | 50.00K | 30.00K | 20.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 107.73M | 82.97M | 50.82M | 24.74M | 20.81M | |||
| Tangible Book Value per Share | 0.03 | 0.23 | 0.44 | 0.70 | 2.38 | |||
| Total Shareholders' Equity | 3.74M | 18.87M | 22.57M | 17.20M | 49.46M | |||
| TOTAL LIABILITIES AND EQUITY | 17.81M | 34.76M | 38.93M | 34.11M | 65.23M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.44 | 0.35 | 0.20 | |||
| Current Ratio | 1.58 | 2.11 | 6.09 | 3.03 | 11.19 | |||
| Return On Assets (ROA) | -243.13% | -140.01% | -84.38% | -138.79% | -54.65% | |||
| Return On Equity (ROE) | -1157.52% | -257.91% | -145.55% | -275.23% | -72.08% | |||
All data in USD